50例新生血管性青光眼临床分析

A clinical analysis of 50 cases neovascular glaucoma

目的:探讨新生血管性青光眼的病因特点,改善其治疗效果。方法;对本院从1990年5月至1996年3月50例新生血管性青光眼患者住院阶段的临床资料进行回顾性分析。结果:新生血管性青光眼的病因主要是视网膜中央静脉阻塞、糖尿病增殖性视网膜病变、视网膜静脉周围炎等。新生血管性青光眼发病潜伏期:视网膜中央静脉阻塞为3.15月,糖尿病视网膜病变近10年。新生血管性青光眼治疗效果差,其致盲率92.4%,阀门植入术优于睫状体冷冻术。结论:新生血管性青光眼是致盲性眼病,阀门植入术是治疗新生血管性青光眼的首选术式。

Purpos: To approach the pathogenic features of neovascular glaucoma and evaluate the effect of treatment. Methods: The medical records of 50 cases neovascular glaucoma between May 1990 and March 1996 were restrospectively analyzed. Results: The causes of neovascular glaucoma were mainly central retinal vein occlusion, diabetic proliferative retinopathy and periphlebitis of retina. The latent periods of neovascular glaucoma were 3.15 months with central retinal vein occlusion and 10 years with diabetic retinopathy respectively. The therapeutic effect of neovascular glaucoma was poor, and its blind-induced rate was 92.4% . The aqueous drainage device implantation was superior to cyclocryotherapy. Conclusions:The neovascular glaucoma is blind-induced ophthalmopathy. The aqueous drainage device implantation is the first choice.